Research Areas
| 4 min read
A synthetic flavone restored vaginal tissue in a preclinical model, offering a potential nonsteroidal treatment for genitourinary syndrome of menopause.
| 4 min read
Psychedelic acquisitions, clinical trial updates, and more led the news this week.
| 5 min read
Aurion Biotech's manufacturing approach to unmodified allogeneic corneal endothelial cells offers a set of hard-won lessons for a cell therapy field still working out how to get from proof-of-concept to broad patient access.
| 3 min read
A new platform combines engineered viral vectors with the brain's glymphatic system to improve gene delivery to glial cells implicated in multiple neurological disorders.
| 3 min read
KCL-286 repaired neuronal DNA damage and reduced neuroinflammation in mice, with prior Phase 1 safety data potentially accelerating its path to Alzheimer's trials.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Automated mass photometry helps reveal the complex dynamics of protein oligomerization and the factors that govern protein assembly.
| 3 min read
Pediatric brain cancer is extremely challenging to treat. Results from a Phase 1 cell therapy trial revealed encouraging long-term survival rates.
| 1 min read
Philip Wills, Chief Commercial Officer of the Cell & Gene Therapy Division at Catalent, reflects on how the gene therapy industry is evolving from early scientific breakthroughs to commercial maturity.
Discover how high-throughput flow cytometry supports antibody, small molecule, and phenotypic screening across drug discovery workflows.
Popular Topics
Multimedia
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Explore how cereblon allostery and cellular target engagement profiling can reveal the mechanisms and selectivity underlying degrader activity.
